By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
AmextaFinanceAmextaFinance
  • Home
  • News
  • Banking
  • Credit Cards
  • Loans
  • Mortgage
  • Investing
  • Markets
    • Stocks
    • Commodities
    • Crypto
    • Forex
  • Videos
  • More
    • Finance
    • Dept Management
    • Small Business
Notification Show More
Aa
AmextaFinanceAmextaFinance
Aa
  • Banking
  • Credit Cards
  • Loans
  • Dept Management
  • Mortgage
  • Markets
  • Investing
  • Small Business
  • Videos
  • Home
  • News
  • Banking
  • Credit Cards
  • Loans
  • Mortgage
  • Investing
  • Markets
    • Stocks
    • Commodities
    • Crypto
    • Forex
  • Videos
  • More
    • Finance
    • Dept Management
    • Small Business
Follow US
AmextaFinance > Markets > Stocks > Kroger to pay up to $1.4 billion to resolve US opioid lawsuits
Stocks

Kroger to pay up to $1.4 billion to resolve US opioid lawsuits

News Room
Last updated: 2023/09/10 at 7:39 AM
By News Room
Share
4 Min Read
SHARE

© Reuters. FILE PHOTO: Kroger logo is displayed in this illustration taken September 5, 2022. REUTERS/Dado Ruvic/Illustration/File Photo

By Nate Raymond

(Reuters) -Kroger on Friday said it would pay as much as $1.4 billion to resolve thousands of lawsuits by U.S. states, local governments and Native American tribes claiming the supermarket chain’s pharmacies helped fuel the nation’s opioid epidemic.

Kroger (NYSE:) agreed to pay up to $1.2 billion to U.S. states, counties and municipalities and $36 million to Native American tribes to resolve the majority of opioid cases it faced. It will also pay $177 million to cover attorneys’ fees and expenses.

Kroger took a $1.4 billion charge related to the tentative settlement, which is dependent on participation by 33 eligible states and the District of Columbia. The $1.2 billion would be paid out over 11 years.

The Cincinnati-based supermarket chain, which is seeking to merge with smaller rival Albertsons, will not admit wrongdoing as part of the deal, and said it will defend against any other claims the tentative settlement does not resolve.

The negotiations that produced the deal were led by attorneys general from California, Colorado, Illinois, North Carolina, Oregon, Tennessee and Virginia.

Thousands of lawsuits have been filed by states, local governments and Native American tribes accusing drug companies of downplaying the risks of opioid painkillers, and distributors and pharmacies of ignoring red flags that they were being trafficked illegally.

The litigation has resulted in more than $51 billion in settlements, according to lawyers for the plaintiffs, with deals already struck with major drugmakers and the nation’s largest distributors.

Kroger itself faced more than 2,000 such lawsuits. In recent months, it had agreed to settle opioid claims by New Mexico for $58.5 million and West Virginia for $62 million.

“These dollars will help save lives, and we will make sure these companies can’t repeat their mistakes,” North Carolina Attorney General Josh Stein, who helped lead negotiations with Kroger, said in a statement.

Friday’s settlement by Kroger followed a collective $13.8 billion in settlements reached last year with three larger pharmacy chain operators, CVS Health Corp (NYSE:), Walgreens Boots Alliance (NASDAQ:) and Walmart (NYSE:).

In a statement on Friday, the lead lawyers representing cities and counties in the litigation – Jayne Conroy, Paul Farrell and Joe Rice – called Kroger’s deal the first by one of the smaller, regional supermarket pharmacies that had played a role in the drug crisis.

“This $1.2 billion agreement-in-principle is another step forward in holding each company that played a role in the opioid epidemic accountable and ensuring hard-hit communities are provided with much-needed resources,” the lawyers said.

Nearly 645,000 people died in the United States from overdoses involving opioids, both prescription and illicit, from 1999 to 2021, according to the U.S. Centers for Disease Control and Prevention.

Read the full article here

News Room September 10, 2023 September 10, 2023
Share this Article
Facebook Twitter Copy Link Print
Leave a comment Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Finance Weekly Newsletter

Join now for the latest news, tips, and analysis about personal finance, credit cards, dept management, and many more from our experts.
Join Now
Why Build-A-Bear Is Quietly Crushing The Market

Watch full video on YouTube

Economic accidents are cockroaches, not termites. 🪳

Watch full video on YouTube

Fraudsters use AI to fake artwork authenticity and ownership

Stay informed with free updatesSimply sign up to the Artificial intelligence myFT…

John Hancock Multimanager Lifestyle Moderate Portfolio Q3 2025 Commentary

A company of Manulife Investment Management, John Hancock Investment Management serves investors…

Role reversal: how foot-dragging France blindsided newly assertive Berlin

German Chancellor Friedrich Merz was making one last push to persuade EU…

- Advertisement -
Ad imageAd image

You Might Also Like

Stocks

CPS reports solid 2023 performance, eyes future growth By Investing.com

By News Room
Stocks

Niu Technologies faces mixed results in Q4 2023 By Investing.com

By News Room
Stocks

Exagen Inc. reports strong 2023 revenue growth By Investing.com

By News Room
Stocks

Legacy Housing reports mixed results amid sales decline By Investing.com

By News Room
Stocks

Harmony Biosciences exec sells over $383k in stock By Investing.com

By News Room
Stocks

Biofrontera posts record revenue and outlines growth plans By Investing.com

By News Room
Stocks

Granite Ridge CFO buys $31,000 in company stock By Investing.com

By News Room
Stocks

Coliseum Capital Management buys MasterCraft Boat shares worth over $3.2m By Investing.com

By News Room
Facebook Twitter Pinterest Youtube Instagram
Company
  • Privacy Policy
  • Terms & Conditions
  • Press Release
  • Contact
  • Advertisement
More Info
  • Newsletter
  • Market Data
  • Credit Cards
  • Videos

Sign Up For Free

Subscribe to our newsletter and don't miss out on our programs, webinars and trainings.

I have read and agree to the terms & conditions
Join Community

2023 © Indepta.com. All Rights Reserved.

YOUR EMAIL HAS BEEN CONFIRMED.
THANK YOU!

Welcome Back!

Sign in to your account

Lost your password?